Using their trading system, Zack's experts give you their prediction for CVS in free RPT. Should you pass or buy CVS? Zacks experts tell all in a new free Special Report.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- Top EV Stocks to Buy Now
Most Useful Ranking List of Medication options. Our top lists help you make informed choices quickly
Search results
- The company is facing higher medical benefit ratios in its Medicare Advantage plans and is ineligible for full level quality bonuses in FY24. However, with a strong outlook for FY25 and a 4.4% dividend yield, CVS remains an attractive investment option if traded correctly.
seekingalpha.com/article/4697775-the-correct-play-on-cvs-health
People also ask
Is CVS Health stock a buy?
Is CVS Health a good investment option for fy25?
Is CVS a good stock to buy in fy24?
Why did CVS Health stock drop 25% in fy24?
Should you buy CVS (CVS)?
Why did CVS share price fall in May?
Jun 6, 2024 · With a strong outlook for FY25, CVS Health remains an attractive investment option if traded correctly. Learn why I rate CVS stock a hold for now.
- CVS Health Stock: Lower Guidance But Risk/Reward Remains ...
CVS Health reported mixed Q4 and FY23 earnings, exceeding...
- CVS Health Stock: Lower Guidance But Risk/Reward Remains ...
3 days ago · October 11, 2024. CVS Health Co. (NYSE:CVS - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-one ratings firms that are covering the stock, Marketbeat reports. Eight analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company.
Feb 15, 2024 · CVS Health reported mixed Q4 and FY23 earnings, exceeding the top line but missing margins on the back of elevated medical costs. Learn why CVS stock is a Buy.
The company has projected its FY24 revenues to be at least $366 billion, above analysts’ estimates of $345.81 billion. In addition, adjusted earnings are forecast to be at least $8.50 per share, in line with Street estimates. Meanwhile, CVS Health reiterated its FY23 guidance.
May 1, 2024 · With a price objective of $95.00, significantly higher than the current price, Lutz’s Buy rating suggests that CVS Health’s stock is poised for a rebound as it navigates through short-term ...
Jun 30, 2024 · CVS Health is an underrated stock to buy right now. Shares of CVS have been rallying after they hit new 52-week lows in May. However, the stock remains cheap, trading at around the...
Dec 6, 2023 · CVS Health sees FY24 adjusted EPS at least $8.50, consensus $8.51. CVS Health back FY23 adjusted EPS view $8.50-$8.70, consensus $8.58. CVS Health to introduce new pharmacy reimbursement...
